Cspc Zhongqi Pharmaceutical Technology Co., Ltd.

This study tests a new drug (glumetinib) combined with chemotherapy in people with advanced stomach cancer or related tumors that have a specific genetic change (MET). The goal is to see if the combination can shrink tumors and control the disease. About 350 adults will take part…

This study is for people with advanced solid tumors that cannot be removed by surgery or have spread. It tests a combination of sirolimus (a drug that may slow cancer growth) with different antibody-drug conjugates (ADCs, which deliver cancer-killing drugs directly to tumor cells…

This study tests whether adding a targeted drug (sirolimus) to a standard hormone therapy (octreotide) can better control advanced neuroendocrine tumors of the stomach, intestines, or pancreas. About 298 adults with tumors that cannot be removed by surgery or have spread will rec…

This study tests an experimental drug called CM326 in people with moderate to severe COPD. The goal is to see if it can reduce the number of serious flare-ups and improve lung function. About 318 adults aged 40-85 will receive either the drug or a placebo for up to a year, with f…

This early-stage study tests a new drug called SYH2085 in healthy Chinese adults to see if it is safe and how the body processes it. About 74 participants will receive either the drug or a placebo. The goal is to gather safety data, not to treat any disease.